Status:
UNKNOWN
S. Aureus Translocation From Skin and Nose to Periprosthetic Tissues
Lead Sponsor:
Rothman Institute Orthopaedics
Conditions:
Staphylococcus Aureus
Eligibility:
All Genders
18+ years
Brief Summary
Surgical site infections (SSI) are a significant clinical issue that requires the use of a great amount of resources. In particular, periprosthetic joint infections (PJIs) have potentially catastrophi...
Eligibility Criteria
Inclusion
- All patients undergoing revision total knee or total hip arthroplasty at our institution will be eligible
Exclusion
- Patients included in other prospective studies
Key Trial Info
Start Date :
October 22 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2021
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04666532
Start Date
October 22 2020
End Date
December 31 2021
Last Update
December 14 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rothman Orthopaedic Institute
Philadelphia, Pennsylvania, United States, 19107